Nanotechnology: A novel approach for treatment of skin disorder
Abstract
Skin, the integument system; pertaining to our body which consists of mainly three layers (i) Epidermis (ii) Dermis (iii) Subcutaneous Tissue. It acts as a protective barrier against many diseases and infections. Skin disorders vary greatly in symptoms and severity. Some may be attributed to situational causes while others may be genetic like atopic dermatitis, melanoma, acne vulgaris, wound healing and psoriasis. Conventional therapies are used to analyze various topical disorders suffers from many limitations i.e. less efficacy, poor patient compliance, and poor bioavailability. Therefore, novel approaches should be investigated for the development of better treatment of the disease. Novel carriers such as Liposome, Niosomes, Ethosomes, Silver nanoparticles, Solid lipid nanoparticles are utilized through almost all the routes of administration to treat dermatological disorders. These Nano systems are used to provide targeted drug delivery and a site-specific delivery of dosage form at a particular receptor site and thus enhance the uptake of poorly soluble drugs and overcome the issues related to poor bioavailability. The root cause for the development of such carriers lies on making the existing drugs more effective and safe for the patients.
Keywords: Skin, Skin disorders, NDDS, Novel Carriers, Nanotechnology
Keywords:
Skin, Skin disorders, NDDS, Novel Carriers, NanotechnologyDOI
https://doi.org/10.22270/jddt.v11i4-S.4945References
Bissett DL. Anatomy and biochemistry of the skin. In: Kydonieus F, Berner B, editors. Transdermal Delivery of Drugs, 1987. p. 29-42.
Gupta M, Agrawal U, Vyas SP. Nano carrier based topical drug delivery for the treatment of skin disorders,2012 ;9(7):783-804.
Dawson AL, Dellavalle RP, Elston DM. Infectious skin diseases: a review, 2012 Jan 1; 30(1):141-51.
Roberts MS, Walters KA. Human skin morphology and dermal absorption, 2008. p. 1-15.
Matsui T, Amagai M. The formation, structure and barrier function of the stratum corneum. International immunology. 2015; 27:269-280. https://doi.org/10.1093/intimm/dxv013
Wysocki AB. Skin anatomy, physiology, and pathophysiology. The Nursing clinics of North America. 1999; 34:777-797.
Eckhart L, Lippens S, Tschachler E, Cell death by cornification. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2013 Dec 1; 1833(12):3471-80.
Sahu SK, Raj R, Raj PM, Alpana R. Topical Lipid Based Drug Delivery Systems for Skin Diseases: A Review. Current Drug Therapy. 2020 Aug 1; 15(4):283-98.
Bouwstra JA, Honeywell-Nguyen PL,Skin structure & mode of action of vesicles. Advanced drug delivery reviews. 2002 Nov 1; 54:S41-55.
Tansey EA, Johnson CD. Recent advances in thermoregulation,Advances in physiology edu Schaefer H, Redelmeier TE. Skin Barrier: Principles of Percutaneous Absorption. Karger, Basel; 1996.
Schaefer H, Redelmeier TE. Skin Barrier: Principles of Percutaneous Absorption. Karger, Basel; 1996
Lawlor KT, Kaur P. Dermal contributions to human inter follicular epidermal architecture and selfrenewal. International journal of molecular sciences. 2015; 16:28098-28107. https://doi.org/10.3390/ijms161226078
Saini S, Dhiman A, Nanda S. Traditional Indian medicinal plants with potential impaired wound healing activity: a review. International Journal of Pharmaceutical Sciences and Research. 2016 May 1; 7(5):1809.
Goon AT, Yosipovitch G, Chan YH, Barrier repair in chronic plaque-type psoriasis. Skin research and technology ;journal of International Society for Bioengineering and the Skin, 2004; 10:10-13.
Rahman M, Akhter S, Ahmad J, Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends. Expert opinion on drug delivery. 2015 Apr 3; 12(4):635-52.
Katare OP, Raza K, Singh B, Dogra S. Novel drug delivery systems in topical treatment of psoriasis, Indian Journal of Dermatology, 2010 Nov 1;76(6):612.
Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN allergy. 2014 Apr 2; 2014.
Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN allergy. 2014 Apr 2; 2014.
Hoare C, Po ALW, Williams H. Systematic review of treatments for atopic eczema. Health Technol. Assess. 2000; 4: 1-191.
Saini S, Dhiman A, Nanda S. Traditional Indian medicinal plants with potential wound healing activity: a review. International Journal of Pharmaceutical Sciences and Research. 2016 May 1; 7(5):1809.
Garg HG and Longaker MT: Scarless Wound Healing. Marcel Dekker, New York, 2000: 1-22. 4.
Reinke JM, Sorg H. Wound repair and regeneration. European Surgical Research. 2012; 49(1):35-43. https://doi.org/10.1159/000339613
Bowe WP, Glick JB, Shalita AR. Updates on topical and oral therapies for acne. Current Dermatology Reports. 2012 Sep 1; 1(3):97-107.
Basic skin structure
Rigon RB, Oyafuso MH, Fujimura AT, Nanotechnology-based drug delivery systems for melanoma anti tumoral therapy: a review. BioMed research international. 2015; 2015.
Lloyd-Hughes H, Shiatis AE, Current & future nanotechnology applications in the management of melanoma: a review. Journal of Nanomedicine , 2015 Nov 1; 6(6):1.
Nacht S, Katz M. The microsponge: A novel delivery system.Drugs and the pharmaceutical sciences. 1990; 42:299-325.
Schmid MH, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Advanced drug delivery review, 1996 Feb 8;18(3):335-42.
Teichmann A, Heuschkel S, Jacobi U,Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion. Eur J Pharm Biopharm, 2007; 66:159-64.
Das R, Nath SS, Bhattacharjee R.,Optical properties of linoleic acid protected gold nanoparticles. Journal of Nanomaterials. 2011 Jan 1.
Nacht S, Katz M. The microsponge: a novel topical programmable delivery system. Drugs and the pharmaceutical sciences. 1990; 42:299-325.
Martin P, Youenang P, Daniel K, Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. 1999; 58:177-87.
Vyas A, Kumar Sonker A, Gidwani B. Carrier based drug delivery system for treatment of acne. The Scientific World Journal, 2014.
Trotta M, Peira E, Carlotti ME, Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004; 270:119-25. https://doi.org/10.1016/j.ijpharm.2003.10.006
Dubey V, Mishra D, Dutta T, Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007; 123:148-54. https://doi.org/10.1016/j.jconrel.2007.08.005
Lakshmi PK, Devi GS, Bhaskaran S, Sacchidanand S. Niosomal methotrexate gel for the treatment of localized psoriasis, 2007; 73:157-61.
Agarwal R, Saraswat A, Kaur I, A novel liposomal formulation of dithranol for psoriasis, 2002; 29:529-32.
Agarwal R, Katare OP, Vyas SP,Preparation & in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm2001; 228:43-52.
Thapa RK, Baskaran R, Madheswaran T,Preparation, characterization and release study of tacrolimus-loaded liquid crystalline nanoparticles. J Disp Sci Technol 2013; 34:72-7. https://doi.org/10.1080/01932691.2011.648462
Wohlrab J, Goebel A, Scherer D, topical tacrolimus microemulsion for plaque-type psoriasis therapy, 2012.
Scognamiglio I, De Stefano D,Campani V, Nanocarriers for topical administration of resveratrol:a comparative study. Int J Pharm2013; 440:179-87.
Pando D, Caddeo C, Manconi M, Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol. J Pharm Pharmacol 2013; 65:1158-67. https://doi.org/10.1111/jphp.12093
Scognamiglio I, De Stefano D,Campani V, Nanocarriers for topical administration of resveratrol:a comparative study. Int J Pharm2013; 440:179-87.
Pople PV and Singh KK,Development and evaluation of colloidal modified lipid carrier: Application to topical delivery of tacrolimus. Eur J Pharm Biopharm. 2011; 79:82-94. https://doi.org/10.1016/j.ejpb.2011.02.016
Fang L, Kong X, Zhao Y, Quan P. Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier. Asian J Pharm Sci. 2016; 11:248-254. https://doi.org/10.1016/j.ajps.2015.07.005
Rosado C, Silva C, Reis CP, Hydrocortisone-loaded poly (ε-caprolactone) nanoparticles for atopic dermatitis treatment. Pharm Dev Technol. 2012; 1-9.
Alam MS, Ali MS, Alam N, In vivo study of clobetasol propionate loaded Nanoemulsion for topical application in psoriasis and atopic dermatitis, 2013; 5: 8-12.
Keck CM, Baspinara Y, Borcherta HH. Development of a positively charged prednicarbate nanoemulsion. Int J Pharm. 2010; 383: 201-208. https://doi.org/10.1016/j.ijpharm.2009.09.002
Kumar A, Agarwal S, Ahuja A, Ali J, Preparation, characterization and in vitro antimicrobial activity of nanocarrier based formulation of nadifloxacin for the treatment of acne. Die Pharmazie-Int. J Pharm Sci. 2011.
De Almeida Borges VR, Simon A, Sena ARC, Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int J Nanomedicine. 2013; 8:535.
Miastkowska M, Sikora E, Ogonowski J, The kinetic study of isotretinoin release from nanoemulsion,Physicochemical and engineering Aspects. 2016 Dec 5; 510:63-8.
Verma P, Pathak K,Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation, 2011.
Garg A, Singh S, Enhancement in antifungal activity of eugenol in immune suppressed rats through lipid nanocarriers.Biointerfaces. 2011 Oct 15; 87(2):280-8.
Michael H, Manuela M-G,Barron Annelise E, Sustained prolonged topical delivery of bioactive human insulin for treatment of cutaneous wounds. Int J Pharm 2010; 398:146-54. https://doi.org/10.1016/j.ijpharm.2010.07.052
Bachhav YG, Mondon K, Kalia YN, Novel micelle formulations to increase cutaneous bioavailability of azole antifungal drug. J Control Release 2011; 153:126-32. https://doi.org/10.1016/j.jconrel.2011.03.003
Bikowski and J. Q. Del Rosso, "Case reports: benzoyl peroxide microsphere cream as monotherapy and combination treatment for acne," Journal of Drugs in Dermatology, 2008; 590-595.
C. L. Dom'ınguez-Delgado, I. M. Rodr'ıguez-Cruz, J. J. Escobar Chavez, "Preparation and characterization of triclosan nanoparticles used for the treatment of acne,"European Journal of Pharmaceutics and Biopharmaceutics, 102-107, 2.
Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Emerging nanopharmaceuticals. Nanomedicine: Nanotechnology, Biology and Medicine. 2008 Dec 1; 4(4):273-82.
Patel SS. Liposome: A versatile platform for targeted delivery of drugs.2006; 4(5):1-5.
Kumar R, Singh B, Bakshi G, Katare OP. Development of liposomal systems of finasteride for topical applications. Pharmaceutical development and technology. 2007 Jan 1; 12(6):591-601.
Yadav JD, Kulkarni PR, Vaidya KA, Niosomes: a review. Journal of Pharmacy Research. 2011 Mar; 4(3):632-6.
Gupta, A., Singh, S., Kotla, N.G., Webster, T.J., Formulation and evaluation of a topical niosomal gel containing a mixture of benzoyl peroxide and tretinoin for anti acne activity, 2014; 24(10), 171-182.
Razavi H, Janfaza S ,Ethosome,A nanocarrier for transdermal drug delivery. Journal of Paramedical Sciences, 2015; 6(2):2008-4978.
Nastiti CM, Ponto T, Abd E, Grice JE, Topical nano and microemulsions for skin delivery. 2017 Sep 21; 9(4):37.
Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections in topical gel formation. Nanomedicine: Nanotechnology. 2012 May 1;8(4):489-96.
Grampurohit, N., Ravikumar, P., Mallya, R., Microemulsions for topical use-a review. Ind. J. Pharm. Edu. Res. 2001; 45(1):100107.
R. P. Bagwe, J. R. Kanicky, B. J. Palla, P. K. Patanjali, "Improved drug delivery using microemulsions: Critical Reviews in Therapeutic Drug Carrier System, 2001, pp. 77-140.
Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery, Eur. J. Pharm. Biopharm.2000; 50(1):161-177. https://doi.org/10.1016/S0939-6411(00)00087-4
Lin, C.H., Fang, Y.P., Al-Suwayeh, S.A., Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with drug for acne treatment, 2003; 36(2):276-286.
Del Rosso JQ, Benzoyl Peroxide Microsphere Formulations, The Journal of clinical and aesthetic dermatology. 2009 Sep;2(9):46-54.
Dinarvand R, Rahmani EL, Farbod E. Gelatin microspheres for the controlled release of all-trans-retinoic acid topical formulation, Iranian Journal of Pharmaceutical Research. 2010; 20(1):47-50.
Chowdhury A, Kunjiappan S, Panneerselvam T, Nanotechnology and nanocarrier-based approaches on treatment of degenerative disorders. International nano letters. 2017 Jun 1; 7(2):91-122.
Garg S, Chandra A, Mazumder A, Mazumder R. Green synthesis of silver nanoparticles using Arnebia nobilis root extract and wound healing potential of its hydrogel. Asian Journal of Pharmaceutics (AJP), 2014; 8(2).
Prabhu S, Poulose EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. 2012 Dec; 2(1):1-0.
Published
Abstract Display: 1165 
PDF Downloads: 983 PDF Downloads: 123 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.